BRCA2 and glioma: In contrast, MGG152, harboring IDH1-R132H and BRCA2 mutations, exhibited modest radiosensitization with IDHi.<h4>Conclusions</h4>Prolonged AGI-5198 exposure does not reduce IR sensitivity in IDH mutant glioma cells.